Literature DB >> 28606236

[Expression of interferon-λ1 in respiratory epithelial cells of children with RSV infection and its relationship with RSV load].

Mei-Ting Tao1, Ya-Ping Xie, Shu-Ping Liu, Hao-Feng Chen, Han Huang, Min Chen, Li-Li Zhong.   

Abstract

OBJECTIVE: To investigate the expression of IFN-λ1 in respiratory epithelial cells of children with respiratory syncytial virus (RSV) infection and its relationship with RSV load.
METHODS: The nasopharyngeal swabs were collected from the children who were hospitalized with respiratory tract infection from June 2015 to June 2016. A direct immunofluorescence assay was used to detect the antigens of seven common respiratory viruses (including RSV) in the nasopharyngeal swabs. A total of 120 children who were only RSV positive were selected as the RSV infection group. A total of 50 children who had negative results in the detection of all viral antigens were selected as the healthy control group. Fluorescence quantitative real-time PCR was used to determine the RSV load and the expression of IFN-λ1 mRNA in the nasopharyngeal swabs of children in the two groups.
RESULTS: The expression of IFN-λ1 in the RSV infection group was significantly higher than that in the healthy control group (P<0.05). The expression of IFN-λ1 was positively correlated with RSV load (r=0.56, P<0.05).
CONCLUSIONS: RSV can induce the expression of IFN-λ1 in respiratory epithelial cells, suggesting that IFN-λ1 may play an important role in anti-RSV infection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28606236      PMCID: PMC7390299     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  13 in total

Review 1.  Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus.

Authors:  Nicole E Pagliaccetti; Michael D Robek
Journal:  J Interferon Cytokine Res       Date:  2010-08       Impact factor: 2.607

Review 2.  Mechanisms of type III interferon expression.

Authors:  Marie B Iversen; Søren R Paludan
Journal:  J Interferon Cytokine Res       Date:  2010-08       Impact factor: 2.607

3.  Role of deficient type III interferon-lambda production in asthma exacerbations.

Authors:  Marco Contoli; Simon D Message; Vasile Laza-Stanca; Michael R Edwards; Peter A B Wark; Nathan W Bartlett; Tatiana Kebadze; Patrick Mallia; Luminita A Stanciu; Hayley L Parker; Louise Slater; Anita Lewis-Antes; Onn M Kon; Stephen T Holgate; Donna E Davies; Sergei V Kotenko; Alberto Papi; Sebastian L Johnston
Journal:  Nat Med       Date:  2006-08-13       Impact factor: 53.440

4.  Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics.

Authors:  Dominique M A Bullens; A Decraene; E Dilissen; I Meyts; K De Boeck; L J Dupont; J L Ceuppens
Journal:  Clin Exp Allergy       Date:  2008-06-28       Impact factor: 5.018

Review 5.  Targeting IFN-λ: therapeutic implications.

Authors:  Mohammed Eslam; Jacob George
Journal:  Expert Opin Ther Targets       Date:  2016-10-11       Impact factor: 6.902

Review 6.  New drugs and treatment for respiratory syncytial virus.

Authors:  Krishan Maggon; Sailen Barik
Journal:  Rev Med Virol       Date:  2004 May-Jun       Impact factor: 6.989

7.  Dexamethasone decreases IL-29 expression in house dust mite-stimulated human bronchial epithelial cells.

Authors:  Mei Lin; Hua-Peng Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16

Review 8.  Interferon induction and function at the mucosal surface.

Authors:  Russell K Durbin; Sergei V Kotenko; Joan E Durbin
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

9.  Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland.

Authors:  Kohei Hasegawa; Tuomas Jartti; Jonathan M Mansbach; Federico R Laham; Alan M Jewell; Janice A Espinola; Pedro A Piedra; Carlos A Camargo
Journal:  J Infect Dis       Date:  2014-11-25       Impact factor: 5.226

10.  Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis.

Authors:  Carla Selvaggi; Alessandra Pierangeli; Marco Fabiani; Lucia Spano; Ambra Nicolai; Paola Papoff; Corrado Moretti; Fabio Midulla; Guido Antonelli; Carolina Scagnolari
Journal:  J Infect       Date:  2014-01-02       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.